THE ROLE OF NUB1 IN PATHOGENESIS OF PARKINSON'S DISEASE
THE ROLE OF NUB1 IN PATHOGENESIS OF PARKINSON'S DISEASE
批准号:
7247146
负责人:
TETSU KAMITANI
金额:
$23.3万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-06-15 至 2010-05-31
关键词:
26S proteasomeBindingBinding ProteinsBinding SitesBiological AssayBrainCellsComplementary DNACultured CellsDefectDevelopmentDiagnostic ProcedureGenesImmunoprecipitationKnock-outLeadLewy BodiesLinkMediatingMethodsMolecularMolecular ChaperonesMutationNeurodegenerative DisordersNumbersOutcomeParkinson DiseasePathogenesisPatientsPlayProtein OverexpressionProteinsRecruitment ActivityReportingResearchRoleScreening procedureSystemTestingUbiquitinUbiquitin Like ProteinsUbiquitinationYeastsalpha synucleinbasedesigndopaminergic neuronhuman SNCAIP proteinknock-downmulticatalytic endopeptidase complexmutantnovelnovel diagnosticsparkin gene/proteinsynucleintherapeutic targetubiquitin-protein ligaseyeast two hybrid system
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the loss of dopaminergic neurons and the presence of cytosolic inclusions, called Lewy bodies (IBs). Mutations in the gene encoding alpha-synuclein, parkin, or synphilin-1 have been reported in patients with familial or sporadic Parkinson's disease. Recently, both alpha-synuclein and synphilin-1 were shown to be ubiquitinated through the E3 ubiquitin ligase activity of wild-type parkin, but not by familial-linked mutant parkin. Moreover, the coexpression of alpha-synuclein, synphilin-1, and parkin resulted in the formation of LB-like ubiquitin-positive cytosolic inclusions in cultured cells. Importantly, familial-linked mutations in parkin disrupted the formation of the ubiquitin-positive inclusions. These observations indicate that defects in the ubiquitination of LB-associated proteins are involved in the pathogenesis of Parkinson's disease. NEDD8 is a ubiquitin-like protein that covalently modifies target proteins in a manner analogous to ubiquitination. Recently, we identified a novel NEDD8-interacting protein, NUB1, that functioned like a molecular chaperone to recruit NEDD8 to the S5a subunit of the 26S proteasome for degradation. In addition to NEDD8, NUB1 interacted with synphilin-1 through its NEDDS-binding site, implying that NUB1 also recruits synphilin-1 to the S5a subunit of the 26S proteasome. Because parkin binds to the same subunit, we hypothesize that NUB1 recruits synphilin-1 to the S5a subunit for its ubiquitination by parkin. Furthermore, we hypothesize that the targeting of synphilin-1 to the S5a subunit is involved not only in the ubiquitination of synphilin-1, but also in LB formation. Indeed, we detected NUB1 in the LBs of brains from patients with Parkinson's disease, suggesting that NUB1 plays a role in LB formation or its breakdown. To test these hypotheses, we will pursue 3 Aims, which are to define 1) the role of NUB1 in the targeting of synphilin-1 to the S5a subunit, 2) the role of NUB1 in the ubiquitination of synphilin-1, and 3) the role of NUB1 in the formation of cytosolic inclusions by synphilin-1. The outcome of our research proposed here will provide a molecular basis for the involvement of NUB1 in the pathogenesis of Parkinson's disease. Furthermore, the outcome will potentially lead to the development of new diagnostic methods and therapeutic targets for Parkinson's disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
THE ROLE OF NUB1 IN PATHOGENESIS OF PARKINSON'S DISEASE
-
批准号:7090310
-
项目类别:
-
资助金额:$24.0万
-
财政年份:2006
-
负责人:TETSU KAMITANI
-
依托单位:
THE ROLE OF NUB1 IN PATHOGENESIS OF PARKINSON'S DISEASE
-
批准号:7672201
-
项目类别:
-
资助金额:$22.84万
-
财政年份:2006
-
负责人:TETSU KAMITANI
-
依托单位:
THE ROLE OF NUB1 IN PATHOGENESIS OF PARKINSON'S DISEASE
-
批准号:7626282
-
项目类别:
-
资助金额:$22.38万
-
财政年份:2006
-
负责人:TETSU KAMITANI
-
依托单位:
NEDD8-MODIFICATION IN VON HIPPEL-LINDAU SYNDROME
-
批准号:6177821
-
项目类别:
-
资助金额:$27.08万
-
财政年份:1999
-
负责人:TETSU KAMITANI
-
依托单位:
NEDD8-MODIFICATION IN VON HIPPEL-LINDAU SYNDROME
-
批准号:6606896
-
项目类别:
-
资助金额:$10.55万
-
财政年份:1999
-
负责人:TETSU KAMITANI
-
依托单位:
NEDD8-MODIFICATION IN VON HIPPEL-LINDAU SYNDROME
-
批准号:2898878
-
项目类别:
-
资助金额:$19.12万
-
财政年份:1999
-
负责人:TETSU KAMITANI
-
依托单位:
NEDD8-MODIFICATION IN VON HIPPEL-LINDAU SYNDROME
-
批准号:6381621
-
项目类别:
-
资助金额:$24.14万
-
财政年份:1999
-
负责人:TETSU KAMITANI
-
依托单位:
NEDD8-MODIFICATION IN VON HIPPEL-LINDAU SYNDROME
-
批准号:6893976
-
项目类别:
-
资助金额:$15.21万
-
财政年份:1999
-
负责人:TETSU KAMITANI
-
依托单位:
NEDD8-MODIFICATION IN VON HIPPEL-LINDAU SYNDROME
-
批准号:6524513
-
项目类别:
-
资助金额:$24.87万
-
财政年份:1999
-
负责人:TETSU KAMITANI
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: